Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000349000

Medchemexpress LLC MASTL Kinase Inhibitor-1 | 1190277-80-5 | 98.1% | 302.33 | 50 MG
SDP

Catalog No. 5000349000
Encompass_Preferred

MKI-1 is an inhibitor of MASTL (microtubule-associated serine/threonine kinase-like) with an IC50 of 9.9 μM. It exhibits antitumor and radiosensitizer activities through PP2A activation in breast cancer.

  • Inhibits MASTL activity in breast cancer cells (5-20 μM)
  • Inhibits oncogenic properties of breast cancer cells at 100 μM, with weaker effects on normal breast cells
  • Reduces serine 62-phosphorylation of c-Myc and total c-Myc, with a decrease in ENSA phosphorylation
  • Reduces c-Myc stability through PP2A activation in MCF7 cells
  • Reduces tumor growth and enhances radiosensitivity in BT549 xenograft model (50 mg/kg, ip, twice a week)

Catalog No. 50-003-49000 Supplier Medchemexpress LLC Supplier No. HY13755250MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MKI-1 is an inhibitor of MASTL (microtubule-associated serine/threonine kinase-like) with an IC50 of 9.9 μM. It exhibits antitumor and radiosensitizer activities through PP2A activation in breast cancer.

  • Inhibits MASTL activity in breast cancer cells (5-20 μM)
  • Inhibits oncogenic properties of breast cancer cells at 100 μM, with weaker effects on normal breast cells
  • Reduces serine 62-phosphorylation of c-Myc and total c-Myc, with a decrease in ENSA phosphorylation
  • Reduces c-Myc stability through PP2A activation in MCF7 cells
  • Reduces tumor growth and enhances radiosensitivity in BT549 xenograft model (50 mg/kg, ip, twice a week)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.